Australia's most trusted
source of pharma news
Saturday, 28 September 2024
Posted 24 September 2024 PM
After 18 years at GSK - including almost three years as Country Manager in Australia - a major career move for Christi Kelsey who has jumped to RNAi specialist, Alnylam.
She announced her new role as Senior Vice President of Value and Pipeline Commercialisation on LinkedIn, joining Alnylam - a pioneer in RNA interference (RNAi) therapeutics - this month.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.